# CG Oncology, Inc.: filings

CGON · Nasdaq · CIK 1991792 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cgon.md) · [Financials](/companies/cgon/financials.md) · [Filings](/companies/cgon/filings.md) · [Insiders](/companies/cgon/insiders.md)

## Reports and events: 50 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 76, 144 45, 8-K 29, 3 16, 10-Q 8, SCHEDULE 13G/A 8, CORRESP 6, SC 13G 6, SCHEDULE 13G 4, 10-K 3, S-1/A 3, SC 13G/A 3, UPLOAD 3, 424B4 2, 424B5 2, ARS 2, DEF 14A 2, DEFA14A 2, DRS 2, EFFECT 2, S-1 2, S-8 2, SCHEDULE 13D 2, SEC STAFF LETTER 2, 4/A 1, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, S-1MEF 1, S-3ASR 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 12:45 ET | [10-Q](/filings/0001193125-26-336918.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336918 |
| 2026-08-06 | 12:30 ET | [8-K](/filings/0001193125-26-336886.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336886 |
| 2026-06-08 | 20:02 ET | [8-K](/filings/0001193125-26-261670.md) | 5.07 Shareholder vote results | 0001193125-26-261670 |
| 2026-05-26 | 12:00 ET | [8-K](/filings/0001193125-26-237908.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-237908 |
| 2026-05-08 | 20:15 ET | [10-Q](/filings/0001193125-26-214669.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214669 |
| 2026-05-08 | 12:45 ET | [8-K](/filings/0001193125-26-213440.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213440 |
| 2026-04-24 | 20:30 ET | [DEF 14A](/filings/0001193125-26-177395.md) | Proxy statement, period 2026-04-23 | 0001193125-26-177395 |
| 2026-04-13 | 12:30 ET | [8-K](/filings/0001193125-26-152044.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-152044 |
| 2026-02-27 | 14:00 ET | [10-K](/filings/0001193125-26-079498.md) | Annual report, period 2025-12-31 | 0001193125-26-079498 |
| 2026-02-27 | 13:45 ET | [8-K](/filings/0001193125-26-079452.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-079452 |
| 2026-01-13 | 21:51 ET | [8-K](/filings/0001193125-26-011855.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-011855 |
| 2026-01-09 | 13:45 ET | [8-K](/filings/0001193125-26-008329.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008329 |
| 2025-11-26 | 12:30 ET | [8-K](/filings/0001193125-25-298160.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-298160 |
| 2025-11-14 | 21:30 ET | [8-K](/filings/0001193125-25-283108.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-283108 |
| 2025-11-14 | 21:15 ET | [10-Q](/filings/0001193125-25-283000.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283000 |
| 2025-11-14 | 13:15 ET | [8-K](/filings/0001193125-25-281672.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281672 |
| 2025-10-28 | 21:12 ET | [SCHEDULE 13D/A](/filings/0001013594-25-001271.md) | Ownership report, active investor, amended | 0001013594-25-001271 |
| 2025-09-18 | 00:37 ET | [SCHEDULE 13D](/filings/0001193125-25-207734.md) | Ownership report, active investor | 0001193125-25-207734 |
| 2025-09-18 | 00:22 ET | [SCHEDULE 13D](/filings/0001013594-25-001163.md) | Ownership report, active investor | 0001013594-25-001163 |
| 2025-09-09 | 11:00 ET | [8-K](/filings/0001991792-25-000007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001991792-25-000007 |
| 2025-09-05 | 11:15 ET | [8-K](/filings/0001991792-25-000004.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001991792-25-000004 |
| 2025-08-08 | 20:15 ET | [10-Q](/filings/0000950170-25-105855.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105855 |
| 2025-08-08 | 12:15 ET | [8-K](/filings/0000950170-25-105487.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105487 |
| 2025-07-11 | 20:15 ET | [8-K](/filings/0000950170-25-095296.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-095296 |
| 2025-06-06 | 20:15 ET | [8-K](/filings/0000950170-25-083088.md) | 5.07 Shareholder vote results | 0000950170-25-083088 |
| 2025-05-13 | 12:30 ET | [10-Q](/filings/0000950170-25-069831.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069831 |
| 2025-05-13 | 12:15 ET | [8-K](/filings/0000950170-25-069825.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069825 |
| 2025-04-28 | 11:30 ET | [8-K](/filings/0000950170-25-058956.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058956 |
| 2025-04-25 | 12:05 ET | [DEF 14A](/filings/0000950170-25-058342.md) | Proxy statement, period 2025-06-05 | 0000950170-25-058342 |
| 2025-03-28 | 12:59 ET | [10-K](/filings/0000950170-25-046351.md) | Annual report, period 2024-12-31 | 0000950170-25-046351 |
| 2025-03-28 | 11:15 ET | [8-K](/filings/0000950170-25-046335.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046335 |
| 2025-03-24 | 12:30 ET | [8-K](/filings/0000950170-25-043497.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043497 |
| 2025-01-10 | 21:15 ET | [8-K](/filings/0000950170-25-004168.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-004168 |
| 2024-12-11 | 21:09 ET | [S-1/A](/filings/0001193125-24-275552.md) | Registration statement, amended | 0001193125-24-275552 |
| 2024-12-11 | 11:06 ET | [S-1](/filings/0001193125-24-274822.md) | Registration statement | 0001193125-24-274822 |
| 2024-12-05 | 12:52 ET | [8-K](/filings/0001193125-24-271116.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271116 |
| 2024-11-12 | 13:17 ET | [10-Q](/filings/0000950170-24-124642.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124642 |
| 2024-11-12 | 13:11 ET | [8-K](/filings/0000950170-24-124636.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124636 |
| 2024-08-08 | 10:19 ET | [10-Q](/filings/0000950170-24-093238.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093238 |
| 2024-08-08 | 10:19 ET | [8-K](/filings/0000950170-24-093237.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093237 |
| 2024-05-24 | 12:15 ET | [8-K](/filings/0000950170-24-064309.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-064309 |
| 2024-05-09 | 12:10 ET | [8-K](/filings/0001193125-24-134805.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134805 |
| 2024-05-09 | 10:07 ET | [10-Q](/filings/0000950170-24-056196.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056196 |
| 2024-05-03 | 20:31 ET | [8-K](/filings/0001193125-24-130800.md) | 8.01 Other events | 0001193125-24-130800 |
| 2024-03-26 | 10:05 ET | [10-K](/filings/0000950170-24-036143.md) | Annual report, period 2023-12-31 | 0000950170-24-036143 |
| 2024-02-16 | 21:21 ET | [8-K](/filings/0001193125-24-038506.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-038506 |
| 2024-01-30 | 12:10 ET | [8-K](/filings/0001193125-24-018715.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-018715 |
| 2024-01-23 | 11:06 ET | [S-1/A](/filings/0001193125-24-012523.md) | Registration statement, amended | 0001193125-24-012523 |
| 2024-01-18 | 11:04 ET | [S-1/A](/filings/0001193125-24-009621.md) | Registration statement, amended | 0001193125-24-009621 |
| 2024-01-02 | 22:16 ET | [S-1](/filings/0001193125-24-000766.md) | Registration statement | 0001193125-24-000766 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.